Suit Says Zynex Directors' Deception Inflated Stock
Medical device manufacturer Zynex Inc. and its directors misled the public and shareholders by reporting increased revenues and product shipments, artificially inflating the company's stock price, according to a shareholder derivative...To view the full article, register now.
Already a subscriber? Click here to view full article